Crossmark

Association of RAAS inhibitors on osteoporosis and fracture risk in the hypertensive population–A prospective population-based cohort study in Lanzhou, China

Crossref DOI link: https://doi.org/10.1186/s12891-024-07909-w

Published Online: 2024-10-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Hongtao

Yang, Mengdi

Sun, Weiming

Zhang, Ruixing

Zhen, Donghu

Tang, Xulei
Funding

Funding for this research was provided by:

Natural Science Foundation of Gansu Province (23JRRA1594, 21JR1RA116, 21JR1RA096)

the Diabetes Clinical Research Project of Shanghai Medical and Health Development Foundation (DMRFP-I-10)

Special Research Fund of Standardized Metabolic Disease Management Center (2018-mmczxjj-3)
License Information

Text and Data Mining valid from 2024-10-09

Version of Record valid from 2024-10-09
More Information

Article History

Received: 19 September 2023

Accepted: 25 September 2024

First Online: 9 October 2024

Declarations

:

: This study was approved by the Ethics Committee of Shanghai Jiao Tong University [approval numbers 2011 (14) and 2014 (52)], and all participants of the original studies included in the REACTIONs have provided informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below